Systematic novel anti-virus treatment method for coronavirus pneumonia

Abstract

The invention discloses a systematic novel anti-virus treatment method for coronavirus pneumonia. According to the systematic novel anti-virus treatment method, [alpha]-interferon, ibovitamide, ribavirin, chloroquine phosphate and arbidol are included. The whole novel anti-virus treatment method for coronavirus pneumonia is optimized, so that the treatment process is more systematized, a patient can be examined before suffering from a disease, and measures such as standard initial examination, initial treatment, anti-virus treatment and critical treatment are implemented when the patient suffers from the disease; the curative effect of antiviral treatment is improved to the greatest extent, a high-level medical service system is built, and high-level diagnosis and treatment services are provided for patients; and when the illness state of the patient deteriorates, the patient can be actively rescued and treated by selecting treatment schemes and measures for the critically ill patient, so that the life of the patient is actively saved, the rescue and treatment survival rate of the critically ill patient is improved, and the case fatality rate is reduced.

Description

technical field [0001] The invention relates to the field of medical technology, in particular to a systematic antiviral treatment method for novel coronavirus pneumonia. Background technique [0002] Novel coronavirus pneumonia, referred to as "new crown pneumonia", is an acute respiratory infectious disease caused by new coronavirus infection. Its common symptoms are fever, dry cough, and fatigue. The transmission routes are direct transmission, aerosol transmission and contact transmission. Patients are accompanied by upper respiratory and gastrointestinal symptoms such as nasal congestion, runny nose, and diarrhea. Severe cases often develop dyspnea a week later, and severe cases rapidly progress to acute respiratory distress syndrome, septic shock, and difficult-to-correct metabolic acidosis It is worth noting that severe and critically ill patients can have moderate to low fever or even no obvious fever during the course of the disease, and mild patients only show low-...

AI Technical Summary

Problems solved by technology

[0003] The existing antiviral treatment methods for novel coronavirus pneumonia are often not systematic enough in the implementation process, and the antiviral treatment methods used are too simple and common, and it is impossible to effectively adopt corresponding treatment measures according to the patient's physical condition. During the pre-inspection of antiviral treatment, it was impossible to carry out all-round inspection, and when the patient was critically ill after antiviral treatment, the corresponding critical treatment measures could not be carried out in time, and the timeliness in the implementation process was relatively low. Difference

Images